Hims & Hers Health (HIMS) has seen sharp price swings and now faces a growing squeeze risk. With a high interest, rising volatility, and a squeeze score of 100, traders on both sides should tread carefully ahead of further analyst downgrades.

Hims & Hers Health, Inc. provides health care software solutions. The Company offers multi-specialty tele-health platform that connects consumers to licensed healthcare providers.

The stock is 35% floated. It has doubled in the last year.

The stock in February doubled the lost half its value.

In February there was a squeeze with the short position falling.

The stock has a crowded score of 75 meaning there is always the risk of a squeeze which increases when the stock rises.

With the stock running recently the squeeze score is 100.

Analysts have begun recommending selling the stock, and fewer are recommending buying

The stock is very volatile which creates risk for the longs and shorts.

With a highly volatile stock, rising short positions, and analyst sentiment turning bearish, HIMS represents a high-risk profile for both short and long positions. The elevated squeeze score further complicates positioning.

Want to know more? Access this data in real time using S3’s BLACK APP

The information herein (some of which has been obtained from third party sources without verification) is believed by S3 Partners, LLC (“S3 Partners”) to be reliable and accurate. Neither S3 Partners nor any of its affiliates makes any representation as to the accuracy or completeness of the information herein or accepts liability arising from its use. Prior to making any decisions based on the information herein, you should determine, without reliance upon S3 Partners, the economic risks, and merits, as well as the legal, tax, accounting, and investment consequences, of such decisions.